gestational age at cordocclusion (CO) are still debated. The goal of this study was to review umbilical cord occlusion procedures in TRAP sequence in relation with outcome. Methods: Review of all cases of elective CO between 2001-2016. CO was performed by bipolar forceps and/or endoscopic laser coagulation. Outcome included survival, intrauterine fetal death (IUFD), termination of pregnancy (TOP), gestational age (GA) at delivery, and premature rupture of membrane (PPROM). Results: Of 107 cases diagnosed at 13,5 (8-23,7) weeks, 13 (12%) CO was not performed due to spontaneous cessation of flow in the mass (n=8, 7%), IUFD (n=4, 4%) or TOP (n=1, 1%). 94 cases, 87 MC twins and 7 triplets underwent CO by laser (n=44, 55%), bipolar forceps (n=17, 21%) coagulation or a combination of both (n=19, 24%) at a median 19.5 weeks. Overall 67 (77%) pump-twins were born alive at 34 (24-38) weeks including 31 (67%) and 36 (88%) when CO was before and after 19 weeks (p=0.02). However, GA at birth was inversely correlated to GA at CO (r = -0,39, p = 0,001). Conclusions: Elective extra fetal cord coagulation allows survival of over 80% of pump-twins. Better outcomes could be achieved by performing surgery after 19 weeks, although earlier procedures, if successful, are associated with fewer preterm deliveries. IUFD occurred in 4% of cases between diagnosis and CO.
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Objectives: To evaluate the perinatal outcomes of the fetuses with severe anemia who underwent intrauterine transfusion (IUT) and to determine whether a correlation exists between the middle cerebral artery-peak systolic velocity (MCA-PSV) and initial hemoglobin level of the fetus before IUT in severe fetal anemia. Methods: This was a single centre study of 58 fetuses treated with IUT for fetal anemia at Asan Medical Centre between 2004 and 2018. Severe fetal anemia was defined as MCA-PSV ≥1.55MoM by ultrasonographic evaluation. Hemoglobin deficit, a difference between normal Hb at each gestational age and measured Hb after cordocentesis, were calculated in fetuses. The difference of 7g/dL or greater was diagnosed with severe anemia. Results: Forty-nine fetuses (84%) were diagnosed with severe fetal anemia according to MCA-PSV value. The four main causes of fetal anemia were idiopathic (39%), viral infection (16%), alloimmunisation (14%), and Twin-twin transfusion syndrome (14%). Eleven fetuses (22%) were demised in utero, 38 fetuses (78%) were born, and 7 neonates died within 5 days after birth. The overall survival was 63%. The most common cause of anemia in demised group was idiopathic (55%), followed by viral infection (22%). The median fetal Hb deficit in severe fetal anemia was 8.5g/dL (range, -2.4-11.4). Twenty-eight fetuses (57%) had fetal Hb deficit of ≥ 7g/dL and 21(43%) had below 7g/dL. In fetuses that had less than 7g/dL difference, relevant discordances existed in their Hb level, varying from 5 to 15.2g/dL. After dividing the severe anemia group according to MCA-PSV value, 1 fetus belonged in a group of 1.55-1.69MoM, 12 fetuses in a group of 1.7-1.99MoM, and 36 fetuses over 2.0MoM. Mean hemoglobin value in each group was 0.3g/dL, 4.57g/dL and 7.67g/dL, respectively. Conclusions: MCA-PSV, although it is known as a good non-invasive method for diagnosis of fetal anemia, it may not be a reliable single independent factor in classifying severity of anemia.
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Twin-reversed arterial perfusion sequence using high-intensity focused ultrasound therapy Objectives: To clinically evaluate high-intensity focused ultrasound (HIFU) for fetal therapy of the twin-reversed arterial perfusion (TRAP) sequence. Methods: Six patients underwent HIFU therapy: five patients during the first trimester and one patient during the second trimester. In this study, two types of HIFU systems were used. The first-generation HIFU system comprised a biaxial transducer and continuous exposure pattern. The second-generation HIFU system comprised a coaxial transducer and sequential exposure pattern. The first-generation apparatus was used for four cases and the second-generation apparatus was used for two cases. Results: For three patients, blood vessels to the acardiac twin had been occluded. Two patients resulted in intrauterine fetal demise despite vessel occlusion. The total fetal survival rate was 67%, and the efficiency rate was 83% after HIFU therapy. After more than 2 years of follow-up, the surviving infants had no severe clinical complications and no postnatal development problems. There was no significant difference in survival rates. However, owing to its efficiency rate, HIFU therapy is beneficial and can reduce the cardiac load of the pump fetus. Conclusions: HIFU does not require uterine puncture for fetal therapy. In this study, there were no fatal complications, such as bleeding, rupture of membranes, and infection. HIFU therapy could be the best method for TRAP sequence treatment in early pregnancy.
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